Altamira Therapeutics Ltd (CYTO) - News Archive

Showing 4 of 4 results.

Altamira Therapeutics Expands Bentrio Distribution, Reinforcing Commitment to Allergy Treatment in Scandinavia

: Altamira Therapeutics Ltd. is making significant strides in expanding its footprint in the Scandinavian pharmaceutical market with the extension of its distribution agreement for Bentrio, a nasal spray designed for th...

Aug 23, 2024 • Major Pharmaceutical Preparations Industry Announcement Bentrio

Bentrio Nasal Spray A Game Changer for Athletes Battling Allergies

In an exciting development for athletes and sports enthusiasts, Altamira Therapeutics Ltd. has recently announced the successful testing of its Bentrio nasal spray, a preservative-free and drug-free solution for allergi...

Aug 16, 2024 • Major Pharmaceutical Preparations Industry Announcement Bentrio

Altamira Therapeutics Utilizes Social Media Channels to Share Positive Results of Nasal Spray Trial for Seasonal Allergic Rhinitis

Altamira Therapeutics Announces Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis via Top Allergy Journal s Social Media ChannelsIn a recent announcement, Altamira Therapeutics Ltd. revealed the dissemin...

May 23, 2024 • Major Pharmaceutical Preparations Industry Clinical Study Bentrio

Altamira Therapeutics and Univercells Group Collaborate to Uphold mRNA Vaccine Delivery

Altamira Therapeutics Joins Forces with Univercells Group to Advance Nanoparticle-Delivered mRNA VaccinesHAMILTON, BERMUDA, March 25, 2024 - Altamira Therapeutics Ltd. (Altamira) (Nasdaq:CYTO), a leading provider of nan...

Mar 25, 2024 • Major Pharmaceutical Preparations Industry Partnership Altamira